IndiaTickerTatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Investor PresentationBSE · investor presentation · 36 pages
VerifiedArchived copy Company dossier
Tatva Chintan Pharma
NSE:TATVA · ISIN INE0GK401011
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Tatva Chintan Pharma
Business
Business evidence pack
Source documentsPrimary material for understanding Tatva Chintan Pharma
Business-model synthesis will be generated from the company's annual reports, investor presentations and conference-call material. Until that layer is reconciled, IndiaTicker shows the source pack instead of company-specific claims.
Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeBSE · conference call · 1 pages
VerifiedArchived copy Analysts/Institutional Investor Meet/Con. Call Updates - Tatva Chintan Pharma Chem LimitedNSE · conference call · 1 pages
VerifiedArchived copy Investor Presentation - Tatva Chintan Pharma Chem LimitedNSE · investor presentation · 36 pages
VerifiedArchived copy Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · conference call · 2 pages
VerifiedArchived copy Annual Report 2025 - Tatva Chintan Pharma Chem LimitedBSE · annual report · 144 pages
VerifiedArchived copy Annual Report FY 2024-2025 - Tatva Chintan Pharma Chem LimitedNSE · annual report · 144 pages
VerifiedArchived copy Annual Report FY 2023-2024 - Tatva Chintan Pharma Chem LimitedNSE · annual report · 294 pages
VerifiedArchived copy General updates - Tatva Chintan Pharma Chem LimitedNSE · annual report · 257 pages
VerifiedArchived copy General updates - Tatva Chintan Pharma Chem LimitedNSE · annual report · 257 pages
VerifiedArchived copy